Arcutis Biotherapeutics, Inc. ARQT Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $415.62M+95.3% | $376.07M+91.3% | $317.93M+129% | $263.47M+99.5% | $212.82M+100% | ||
| $37.65M+52.4% | $36.7M+91.8% | $31.91M+121% | $28.73M+183% | $24.7M+231% | ||
| $377.98M+101% | $339.38M+91.3% | $286.02M+130% | $234.74M+92.5% | $188.12M+90.1% | ||
| 90.9%+2.5pp | 90.2%0.0pp | 90%+0.4pp | 89.1%-3.2pp | 88.4%-4.6pp | ||
| $90.14M+27.3% | $77.05M+0.8% | $71.08M-17.1% | $70.98M-23.2% | $70.82M-28.0% | ||
| $284.63M+19.3% | $274.55M+19.7% | $253.18M+14.8% | $249.6M+19.3% | $238.6M+21.1% | ||
| $412.41M+23.4% | $388.3M+19.5% | $356.18M+11.1% | $349.3M+12.0% | $334.12M+10.3% | ||
| —— | —— | -$38.25M+79.0% | -$85.84M+52.3% | -$121.3M+38.3% | ||
| $13.47M-40.6% | $12.08M-55.5% | $14.63M-50.2% | $18.22M-39.9% | $22.67M-24.8% | ||
| —— | —— | —— | —— | —— | ||
| $985K+63.6% | $1.17M+81.0% | $1.02M+193% | $944K-72.0% | $602K-82.1% | ||
| —— | —— | -$44.32M+77.3% | -$93.27M+53.1% | -$129.72M+40.3% | ||
| —— | —— | -$0.35+78.9% | -$0.74+64.1% | -$1.03+63.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s revenue?
- Arcutis Biotherapeutics, Inc. (ARQT) generated $415.6M in revenue over the trailing twelve months, up 95.3% year over year.
- Is Arcutis Biotherapeutics, Inc. profitable?
- Arcutis Biotherapeutics, Inc. is not currently profitable: it reported a net loss of $44.8M over the trailing twelve months, a -13.9% net margin.
- What are Arcutis Biotherapeutics, Inc.'s profit margins?
- Gross margin is 90.9% and operating margin is -12.0%, with a -13.9% net margin.
- What is Arcutis Biotherapeutics, Inc.'s earnings per share?
- Arcutis Biotherapeutics, Inc.'s diluted EPS over the trailing twelve months is $-0.36.
- Where does Arcutis Biotherapeutics, Inc.'s income statement data come from?
- Every line is extracted from Arcutis Biotherapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
